Monday 17 November 2014

No safety concerns yet in trials of GSK's Ebola vaccine

The logo of GlaxoSmithKline is seen on its office building in Shanghai By Kate Kelland LONDON (Reuters) - Almost 200 people have received GlaxoSmithKline's experimental Ebola vaccine in trials in the United States, Britain, Mali and Switzerland, and the safety data so far are "very satisfactory", scientists said on Monday. The trials, which began just over two months ago, have been using healthy volunteers, rather than patients with Ebola, to test whether the vaccine is safe for humans. The experimental shot uses a single Ebola virus gene from a chimpanzee virus to generate an immune response. ...




via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment